Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 30 days matching "early-stage research"

ResearchRSS2 days ago

AAN 2026: Crexont linked to more on time in new Parkinson’s study

Researchers found that a Parkinson's disease medication called Crexont helped patients spend more time feeling better and less time experiencing symptoms when they switched from other levodopa treatments. The study showed improvements in movement control and daily functioning across different patient groups. This is early-stage research being presented at a medical conference.

WHY IT MATTERSIf you take levodopa for Parkinson's and struggle with 'off' periods when symptoms return between doses, Crexont may offer a way to extend your good symptom control time throughout the day.
💬 Ask your doctorParkinson's diseaseRead →
ResearchBIORXIVApr 18

Preprint: Proteomics signatures associated with cognitive trajectories: evidence from the English Longitudinal Study of Ageing

Researchers studied blood proteins in over 2,400 older adults to find which ones might predict memory and thinking problems later in life. They found 34 proteins linked to faster decline in orientation (knowing where you are and what time it is) and 18 proteins linked to memory loss over 15 years. This early-stage research could help doctors identify people at risk for dementia before symptoms appear.

WHY IT MATTERSIf validated, these protein signatures could enable blood tests to identify people at risk for cognitive decline years before symptoms develop, potentially opening windows for preventive treatments in Alzheimer's disease and related dementias.
👁 Watch this spaceAlzheimer's diseaseAlzheimer's disease and related dementiasRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases